The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

R. Joe; Y. Matsumura; A. Siddiqui; J. Foulks; M. Beg; J. Thompson; N. Yamamoto; A. Spira; J. Sarantopoulos; J. Melear; Y. Lou; C. Lebedinsky; J. Li; A. Watanabe; S. Warner

doi:10.1016/S0959-8049(22)00954-6

The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

R. Joe, Y. Matsumura, A. Siddiqui, J. Foulks, M. Beg, J. Thompson, N. Yamamoto, A. Spira, J. Sarantopoulos, J. Melear, Y. Lou, C. Lebedinsky, J. Li, A. Watanabe, S. Warner

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S57-S58
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00954-6
State	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)00954-6

Cite this

Joe, R., Matsumura, Y., Siddiqui, A., Foulks, J., Beg, M., Thompson, J., Yamamoto, N., Spira, A., Sarantopoulos, J., Melear, J., Lou, Y., Lebedinsky, C., Li, J., Watanabe, A., & Warner, S. (2022). The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. European Journal of Cancer, 174, S57-S58. https://doi.org/10.1016/S0959-8049(22)00954-6

Joe, R, Matsumura, Y, Siddiqui, A, Foulks, J, Beg, M, Thompson, J, Yamamoto, N, Spira, A, Sarantopoulos, J, Melear, J, Lou, Y, Lebedinsky, C, Li, J, Watanabe, A & Warner, S 2022, 'The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models', European Journal of Cancer, vol. 174, pp. S57-S58. https://doi.org/10.1016/S0959-8049(22)00954-6

@article{dc1b352ed8da40a88b38b02dd135d08f,

title = "The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models",

author = "R. Joe and Y. Matsumura and A. Siddiqui and J. Foulks and M. Beg and J. Thompson and N. Yamamoto and A. Spira and J. Sarantopoulos and J. Melear and Y. Lou and C. Lebedinsky and J. Li and A. Watanabe and S. Warner",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00954-6",

language = "English (US)",

volume = "174",

pages = "S57--S58",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

AU - Joe, R.

AU - Matsumura, Y.

AU - Siddiqui, A.

AU - Foulks, J.

AU - Beg, M.

AU - Thompson, J.

AU - Yamamoto, N.

AU - Spira, A.

AU - Sarantopoulos, J.

AU - Melear, J.

AU - Lou, Y.

AU - Lebedinsky, C.

AU - Li, J.

AU - Watanabe, A.

AU - Warner, S.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140454116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140454116&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00954-6

DO - 10.1016/S0959-8049(22)00954-6

M3 - Article

AN - SCOPUS:85140454116

SN - 0959-8049

VL - 174

SP - S57-S58

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this